EUVIMEDEUVIMED entdecken
Crossref

Patterns of Care and Outcomes of Neoadjuvant Chemotherapy or Primary Surgery in Stage III-IV Ovarian Cancer: An Ancillary Study of GOG 262

John K. Chan, Helen Huang, Laura L. Holman, Paul DiSilvestro, Saketh Guntupalli, David M. Kushner, Elena S. Ratner, Nitika Thawani, Daniel S. Kapp, Krishnansu S. Tewari, Bradley J. Monk

JCO Oncology Advances · 2026-04 · 3 (2)

DOI: 10.1200/oa-25-00157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Advances, 2026-04. Verfasst von John K. Chan und 10 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE To determine factors and survival of patients with ovarian cancer after primary debulking surgery followed by adjuvant chemotherapy (PDS) versus neoadjuvant chemotherapy followed by interval cytoreduction (NAC). METHODS GOG-262 was a prospective randomized trial evaluating once per week dose dense chemotherapy. The physicians were given the option of performing PDS versus NAC. Chi-squared tests and Kaplan-Meier procedures were used for analyses. RESULTS Of 192 patients from centers offering both treatment options, 119 (62%) patients had PDS and 73 (38%) underwent NAC. Compared with the PDS group, NAC patients were older (60 years and older) age (67% v 47%; P < .01) and had more advanced (stage IV) disease (41.1% v 26.1%, P < .01) and peritoneal versus ovarian or fallopian tube cancers (16.4% v 5.0%, P < .001). The 5-year unadjusted overall survival of patients after NAC was 41.9 versus 47.8 months in the PDS group. After adjusting for prognostic factors, PDS was not an independent predictor for survival (hazard ratio [HR], 1.08 [95% CI, 0.67 to 1.7]; P = .75), whereas more advanced (IV v II/III)-stage (HR, 1.9 [95% CI, 0.93 to 3.89]; P = .079) and peritoneal versus ovarian or fallopian tube cancers (HR, 4.36 [95% CI, 1.45 to 13.1]; P = .009) were associated with poorer survival. CONCLUSION Compared with primary surgery followed by chemotherapy, neoadjuvant chemotherapy followed by interval surgery patients were older and had more advanced disease (stage IV v II-III) and more primary peritoneal cancer ( v ovarian and fallopian tube cancer). The survival of these two groups was comparable after adjusting for prognostic factors.

Zitieren

APA

Chan, J. K., Huang, H., Holman, L. L., DiSilvestro, P., Guntupalli, S., Kushner, D. M., Ratner, E. S., Thawani, N., Kapp, D. S., Tewari, K. S., & Monk, B. J. (2026). Patterns of Care and Outcomes of Neoadjuvant Chemotherapy or Primary Surgery in Stage III-IV Ovarian Cancer: An Ancillary Study of GOG 262. JCO Oncology Advances, 3(2). https://doi.org/10.1200/oa-25-00157

Vancouver

Chan JK, Huang H, Holman LL, DiSilvestro P, Guntupalli S, Kushner DM, et al. Patterns of Care and Outcomes of Neoadjuvant Chemotherapy or Primary Surgery in Stage III-IV Ovarian Cancer: An Ancillary Study of GOG 262. JCO Oncology Advances. 2026;3(2). doi:10.1200/oa-25-00157

BibTeX
@article{Chan2026,
  author = {Chan, John K. and Huang, Helen and Holman, Laura L. and DiSilvestro, Paul and Guntupalli, Saketh and Kushner, David M. and Ratner, Elena S. and Thawani, Nitika and Kapp, Daniel S. and Tewari, Krishnansu S. and Monk, Bradley J.},
  title = {Patterns of Care and Outcomes of Neoadjuvant Chemotherapy or Primary Surgery in Stage III-IV Ovarian Cancer: An Ancillary Study of GOG 262},
  journal = {JCO Oncology Advances},
  year = {2026},
  volume = {3},
  number = {2},
  doi = {10.1200/oa-25-00157}
}
Kostenlos starten →